Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Rational design of an argon-binding superelectrophilic anion.

Mayer M, van Lessen V, Rohdenburg M, Hou GL, Yang Z, Exner RM, Aprà E, Azov VA, Grabowsky S, Xantheas SS, Asmis KR, Wang XB, Jenne C, Warneke J.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8167-8172. doi: 10.1073/pnas.1820812116. Epub 2019 Apr 5.

PMID:
30952786
2.

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Gnant M, Pfeiler G, Steger GG, Egle D, Greil R, Fitzal F, Wette V, Balic M, Haslbauer F, Melbinger-Zeinitzer E, Bjelic-Radisic V, Jakesz R, Marth C, Sevelda P, Mlineritsch B, Exner R, Fesl C, Frantal S, Singer CF; Austrian Breast and Colorectal Cancer Study Group.

Lancet Oncol. 2019 Mar;20(3):339-351. doi: 10.1016/S1470-2045(18)30862-3. Epub 2019 Feb 19.

PMID:
30795951
3.

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases.

Bergen ES, Berghoff AS, Medjedovic M, Rudas M, Fitzal F, Bago-Horvath Z, Dieckmann K, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R.

Clin Cancer Res. 2019 May 1;25(9):2737-2744. doi: 10.1158/1078-0432.CCR-18-1968. Epub 2019 Jan 15.

PMID:
30647078
4.

Synthesis and Derivatization of 1,1-[18 F]Difluorinated Alkenes.

Frost AB, Brambilla M, Exner RM, Tredwell M.

Angew Chem Int Ed Engl. 2019 Jan 8;58(2):472-476. doi: 10.1002/anie.201810413. Epub 2018 Dec 6.

PMID:
30452114
5.

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.

Strobl S, Wimmer K, Exner R, Devyatko Y, Bolliger M, Fitzal F, Gnant M.

Curr Treat Options Oncol. 2018 Mar 12;19(4):18. doi: 10.1007/s11864-018-0535-z. Review.

PMID:
29527635
6.

Optimal duration of adjuvant endocrine therapy: how to apply the newest data.

Wimmer K, Strobl S, Bolliger M, Devyatko Y, Korkmaz B, Exner R, Fitzal F, Gnant M.

Ther Adv Med Oncol. 2017 Nov;9(11):679-692. doi: 10.1177/1758834017732966. Epub 2017 Oct 27. Review.

7.

Local therapies for breast cancer.

Exner R.

Memo. 2017;10(3):181-184. doi: 10.1007/s12254-017-0336-2. Epub 2017 Jun 7. Review.

8.

Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials.

Krois W, Romar AK, Wild T, Dubsky P, Exner R, Panhofer P, Jakesz R, Gnant M, Fitzal F.

Breast Cancer Res Treat. 2017 Jul;164(2):421-427. doi: 10.1007/s10549-017-4255-z. Epub 2017 May 2.

9.

Trocar-site evisceration of the vermiform appendix following laparoscopic sigmoid colectomy: A case report.

Bhangu JS, Exner R, Bachleitner-Hofmann T.

Int J Surg Case Rep. 2017;31:273-275. doi: 10.1016/j.ijscr.2017.01.066. Epub 2017 Feb 1.

10.

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.

Singer CF, Tan YY, Fitzal F, Steger GG, Egle D, Reiner A, Rudas M, Moinfar F, Gruber C, Petru E, Bartsch R, Tendl KA, Fuchs D, Seifert M, Exner R, Balic M, Bago-Horvath Z, Filipits M, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2017 Jul 15;23(14):3676-3683. doi: 10.1158/1078-0432.CCR-16-2373. Epub 2017 Jan 31.

11.

Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.

Exner R, Sachet M, Arnold T, Zinn-Zinnenburg M, Michlmayr A, Dubsky P, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R.

Cancer Med. 2016 Sep;5(9):2350-8. doi: 10.1002/cam4.827. Epub 2016 Jul 25.

12.

Prognostic impact of breast cancer subtypes in elderly patients.

Bergen ES, Tichy C, Berghoff AS, Rudas M, Dubsky P, Bago-Horvath Z, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R.

Breast Cancer Res Treat. 2016 May;157(1):91-9. doi: 10.1007/s10549-016-3787-y. Epub 2016 Apr 23.

13.

Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers.

Exner R, Pulverer W, Diem M, Spaller L, Woltering L, Schreiber M, Wolf B, Sonntagbauer M, Schröder F, Stift J, Wrba F, Bergmann M, Weinhäusel A, Egger G.

Br J Cancer. 2015 Sep 29;113(7):1035-45. doi: 10.1038/bjc.2015.303. Epub 2015 Sep 3.

14.

Adjuvant Bisphosphonates and Breast Cancer Survival.

Strobl S, Korkmaz B, Devyatko Y, Schuetz M, Exner R, Dubsky PC, Jakesz R, Gnant M.

Annu Rev Med. 2016;67:1-10. doi: 10.1146/annurev-med-053014-103600. Epub 2015 Aug 28. Review.

PMID:
26332000
15.

Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy.

Promberger R, Dubsky P, Mittlböck M, Ott J, Singer C, Seemann R, Exner R, Panhofer P, Steger G, Bergen E, Gnant M, Jakesz R, Bago-Horvath Z, Rudas M, Bartsch R.

Clin Breast Cancer. 2015 Dec;15(6):505-11. doi: 10.1016/j.clbc.2015.06.007. Epub 2015 Jun 18.

PMID:
26195436
16.

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.

Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group.

Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3. Epub 2015 May 31.

PMID:
26040499
17.

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer.

Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retèl VP, Fitzal F, Rudas M, Singer C, Pfeiler G, Gnant M, Jakesz R, Dubsky P.

Br J Cancer. 2014 Aug 26;111(5):837-42. doi: 10.1038/bjc.2014.339. Epub 2014 Jul 8.

18.

Evaluation of Mycobacterium tuberculosis drug susceptibility in clinical specimens from Nigeria using genotype MTBDRplus and MTBDRsl assays.

Felkel M, Exner R, Schleucher R, Lay H, Autenrieth IB, Kempf VA, Frick JS.

Eur J Microbiol Immunol (Bp). 2013 Dec;3(4):252-7. doi: 10.1556/EuJMI.3.2013.4.3. Epub 2013 Nov 21.

19.

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer.

Pfeiler G, Königsberg R, Hadji P, Fitzal F, Maroske M, Dressel-Ban G, Zellinger J, Exner R, Seifert M, Singer C, Gnant M, Dubsky P.

Br J Cancer. 2013 Sep 17;109(6):1522-7. doi: 10.1038/bjc.2013.499. Epub 2013 Sep 3.

20.

Heavy metal removal from sewage sludge ash by thermochemical treatment with polyvinylchloride.

Vogel C, Exner RM, Adam C.

Environ Sci Technol. 2013 Jan 2;47(1):563-7.

PMID:
23189972
21.

Incidental appendectomy--standard or unnecessary additional trauma in surgery for colorectal cancer? A retrospective analysis of histological findings in 380 specimens.

Exner R, Sachsenmaier M, Horvath Z, Stift A.

Colorectal Dis. 2012 Oct;14(10):1262-6. doi: 10.1111/j.1463-1318.2012.02933.x.

PMID:
22230025
22.

Objectively measured breast symmetry has no influence on quality of life in breast cancer patients.

Exner R, Krois W, Mittlböck M, Dubsky P, Jakesz R, Gnant M, Fitzal F.

Eur J Surg Oncol. 2012 Feb;38(2):130-6. doi: 10.1016/j.ejso.2011.10.012. Epub 2011 Dec 5.

PMID:
22152943
23.

Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?

Gnant M, Blaha P, Dubsky P, Exner R, Fitzal F, Sporn E, Panhofer P, Borgo AD, Bigenzahn S, Steger G, Jakesz R.

Ther Adv Med Oncol. 2009 Nov;1(3):123-36. doi: 10.1177/1758834009344594.

24.

Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio.

Blaha P, Exner R, Borgo AD, Bigenzahn S, Panhofer P, Riedl O, Schoppmann S, Bachleitner-Hofmann T, Sporn E, Pluschnig U, Fitzal F, Steger G, Jakesz R, Dubsky P, Gnant M.

Breast Care (Basel). 2009;4(3):155-161. Epub 2009 Jun 23.

25.

Continuous therapeutic epinephrine but not norepinephrine prolongs splanchnic IL-6 production in porcine endotoxic shock.

Bergmann M, Gornikiewicz A, Tamandl D, Exner R, Roth E, Függer R, Götzinger P, Sautner T.

Shock. 2003 Dec;20(6):575-81.

PMID:
14625484
26.

Surgical treatment of severe acute pancreatitis: timing of operation is crucial for survival.

Götzinger P, Wamser P, Exner R, Schwanzer E, Jakesz R, Függer R, Sautner T.

Surg Infect (Larchmt). 2003 Summer;4(2):205-11.

PMID:
12906721
27.
28.

Regulative potential of glutamine--relation to glutathione metabolism.

Roth E, Oehler R, Manhart N, Exner R, Wessner B, Strasser E, Spittler A.

Nutrition. 2002 Mar;18(3):217-21. Review.

PMID:
11882392
29.

Glutamine deficiency renders human monocytic cells more susceptible to specific apoptosis triggers.

Exner R, Weingartmann G, Eliasen MM, Gerner C, Spittler A, Roth E, Oehler R.

Surgery. 2002 Jan;131(1):75-80.

PMID:
11812966
30.

Therapeutic potential of glutathione.

Exner R, Wessner B, Manhart N, Roth E.

Wien Klin Wochenschr. 2000 Jul 28;112(14):610-6. Review.

PMID:
11008322
31.

Gene-dependent effect of lithium on circadian rhythms in mice (Mus musculus).

Possidente B, Exner RH.

Chronobiol Int. 1986;3(1):17-21.

PMID:
3677192

Supplemental Content

Support Center